Cargando…

Detection of SARS-CoV-2–Specific Antibodies in Human Breast Milk and Their Neutralizing Capacity after COVID-19 Vaccination: A Systematic Review

SARS-CoV-2 is the virus that causes the infectious disease known as Corona Virus Disease 2019 (COVID-19). The severe impact of the virus on humans is undeniable, which is why effective vaccines were highly anticipated. As of 12 January 2022, nine vaccines have obtained Emergency Use Listing by the W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nicolaidou, Vicky, Georgiou, Rafaela, Christofidou, Maria, Felekkis, Kyriacos, Pieri, Myrtani, Papaneophytou, Christos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917673/ https://www.ncbi.nlm.nih.gov/pubmed/36769279 http://dx.doi.org/10.3390/ijms24032957

Ejemplares similares

Alterations in Circulating miRNA Levels after Infection with SARS-CoV-2 Could Contribute to the Development of Cardiovascular Diseases: What We Know So Far
por: Pieri, Myrtani, et al.
Publicado: (2023)

Exploring the Feasibility of Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Osteoarthritis: Challenges and Opportunities
por: Felekkis, Kyriacos, et al.
Publicado: (2023)

Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in Cyprus
por: Papaneophytou, Christos, et al.
Publicado: (2022)

Survival of Vaccine-Induced Human Milk SARS-CoV-2 IgG, IgA and SIgA Immunoglobulins across Simulated Human Infant Gastrointestinal Digestion
por: Pieri, Myrtani, et al.
Publicado: (2022)

Special Issue: The Impact of Early Life Nutrition on Gut Maturation and Later Life Gut Health
por: Pieri, Myrtani, et al.
Publicado: (2023)

Challenges in Using Circulating Micro-RNAs as Biomarkers for Cardiovascular Diseases
por: Felekkis, Kyriacos, et al.
Publicado: (2020)

A bovine miRNA, bta‐miR‐154c, withstands in vitro human digestion but does not affect cell viability of colorectal human cell lines after transfection
por: Pieri, Myrtani, et al.
Publicado: (2022)

SARS-CoV-2 and HIV-1: So Different yet so Alike. Immune Response at the Cellular and Molecular Level
por: Demoliou, Catherine, et al.
Publicado: (2022)

COVID-19 and human milk: SARS-CoV-2, antibodies, and neutralizing capacity
por: Pace, Ryan M., et al.
Publicado: (2020)

Targeting Lactate Dehydrogenase-B as a Strategy to Fight Cancer: Identification of Potential Inhibitors by In Silico Analysis and In Vitro Screening
por: Vlasiou, Manos, et al.
Publicado: (2023)

Characterization of SARS-CoV-2 RNA, Antibodies, and Neutralizing Capacity in Milk Produced by Women with COVID-19
por: Pace, Ryan M., et al.
Publicado: (2021)

Is suppression of cyst growth in PKD enough to preserve renal function?: STAT6 inhibition is a novel promising target
por: Deltas, Constantinos, et al.
Publicado: (2012)

Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
por: Bekliz, Meriem, et al.
Publicado: (2022)

CNVs-microRNAs Interactions Demonstrate Unique Characteristics in the Human Genome. An Interspecies in silico Analysis
por: Dweep, Harsh, et al.
Publicado: (2013)

SARS-CoV-2 re-infection, vaccination and neutralizing antibodies
por: Bongiovanni, Marco, et al.
Publicado: (2022)

Hexamerization of Anti-SARS CoV IgG1 Antibodies Improves Neutralization Capacity
por: Pande, Kalyan, et al.
Publicado: (2022)

Immunogenic fusion proteins induce neutralizing SARS-CoV-2 antibodies in the serum and milk of sheep
por: Jacobson, Gregory M., et al.
Publicado: (2023)

Chitosan Nanogel with Mixed Food Plants and Its Relation to Blood Glucose in Type 2 Diabetes: A Systematic and Meta-Analysis Review of Observational Studies
por: Aloysius, Morris, et al.
Publicado: (2022)

Inhibitor screening using microarray identifies the high capacity of neutralizing antibodies to Spike variants in SARS-CoV-2 infection and vaccination
por: Zhang, Xiaomei, et al.
Publicado: (2022)

Antibody Avidity Maturation Following Recovery From Infection or the Booster Vaccination Grants Breadth of SARS-CoV-2 Neutralizing Capacity
por: Nakagama, Yu, et al.
Publicado: (2022)

Down‐regulation of SARS‐CoV‐2 neutralizing antibodies in vaccinated smokers
por: Zhang, Jiahui, et al.
Publicado: (2022)

Correlation of SARS-CoV-2 Neutralization with Antibody Levels in Vaccinated Individuals
por: Chowdhury, Shazeda Haque, et al.
Publicado: (2023)

The role of oligodendrocyte gap junctions in neuroinflammation
por: Papaneophytou, Christos, et al.
Publicado: (2019)

Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities
por: Noval, Maria G., et al.
Publicado: (2021)

Serological anti-SARS-CoV-2 neutralizing antibodies association to live virus neutralizing test titers in COVID-19 paucisymptomatic/symptomatic patients and vaccinated subjects
por: Cristiano, Antonio, et al.
Publicado: (2021)

Inactivated Vaccines Against SARS-CoV-2: Neutralizing Antibody Titers in Vaccine Recipients
por: Zhang, Haiying, et al.
Publicado: (2022)

Performance comparison of micro-neutralization assays based on surrogate SARS-CoV-2 and WT SARS-CoV-2 in assessing virus-neutralizing capacity of anti-SARS-CoV-2 antibodies
por: Sekirov, Inna, et al.
Publicado: (2021)

Impact of Covishield Vaccination in Terms of SARS CoV-2 Neutralizing Antibody Expression
por: Thomas, Rhema Elizabeth, et al.
Publicado: (2022)

Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies
por: Sharun, Khan, et al.
Publicado: (2021)

Detection of SARS-CoV-2 Nucleocapsid, Spike, and Neutralizing Antibodies in Vaccinated Japanese
por: Midorikawa, Rie, et al.
Publicado: (2022)

Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children
por: Laub, Otto, et al.
Publicado: (2021)

Associations between serum biomarkers of cartilage metabolism and serum hyaluronic acid, with risk factors, pain categories, and disease severity in knee osteoarthritis: a pilot study
por: Papaneophytou, Christos, et al.
Publicado: (2022)

Antibody-mediated neutralization of SARS-CoV-2
por: Gruell, Henning, et al.
Publicado: (2022)

Neutralizing antibodies for SARS-CoV-2 infection
por: Berenguer, Juan
Publicado: (2022)

Development of a rapid neutralizing antibody test for SARS-CoV-2 and its application for neutralizing antibody screening and vaccinated serum testing
por: Li, Yuchang, et al.
Publicado: (2022)

COVID-19 Neutralizing Antibodies in Breast Milk of Mothers Vaccinated with Three Different Vaccines in Mexico
por: Cabanillas-Bernal, Olivia, et al.
Publicado: (2022)

Anti-SARS-CoV-2 Spike Antibody Titers and Neutralizing Antibodies in Vaccinated Rheumatoid Arthritis Patients
por: Furukawa, Hiroshi, et al.
Publicado: (2022)

Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration
por: Follmann, Dean, et al.
Publicado: (2023)

Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma
por: von Rhein, Christine, et al.
Publicado: (2021)

Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization Capacity
por: Phelan, Thomas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3jqu0mvpo79inuks8k3rh8ap8u